Free shipping on all orders over $ 500

LY3039478

Cat. No. M2827

All AbMole products are for research use only, cannot be used for human consumption.

LY3039478 Structure
Synonym:

Crenigacestat

Size Price Availability Quantity
2mg USD 96 In stock
5mg USD 136 In stock
10mg USD 220 In stock
25mg USD 440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LY3039478 (Crenigacestat) is a novel and orally active Notch and γ-secretase inhibitor, with an IC50 of 1 nM in most of the tumor cell lines tested. Crenigacestat (LY3039478) decreases expression of Myc and cyclin A1 (part of the NOTCH-driven proliferative signature) in murine and human model systems. Crenigacestat (LY3039478) treatment also leads to G0/G1 cell cycle arrest in CCRCC cells.

Customer Product Validations & Biological Datas
Source J Biol Chem (2017). Figure 6. LY3039478
Method qRT-PCR
Cell Lines CCRCC cell lines
Concentrations 1 μM
Incubation Time -
Results Treatment with a secretase inhibitor that is being tested in clinical trials, LY3039478, significantly inhibited the growth of 2 CCRCC cell lines in a concentrationdependent manner
Chemical Information
Molecular Weight 464.44
Formula C22H23F3N4O4
CAS Number 1421438-81-4
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Margot J Pont, et al. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma

[2] Olivier Mir, et al. Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

[3] C Massard, et al. First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

Related Gamma-secretase/Beta-secretase Products
DAPT

DAPT (GSI-IX) is a γ-secretase inhibitor with IC50 values of 115 and 200 nM for total Aβ and Aβ42 respectively. DAPT inhibits the activation of Notch 1 signaling.

BMS-708163

BMS-708163 (Avagacestat) is a selective γ-secretase inhibitor (IC50 = 0.3 nM).

RO4929097

RO4929097 is a potent and selective inhibitor of γ-secretase and as a result is able to inhibit Notch pathway signaling.

MK-0752

MK-0752 is a potent, oral inhibitor of γ-secretase with IC50 of 5 nM in human SH-SY5Y cells.

LY-411575

LY-411575 is potent and selective small molecule γ-secretase inhibitor with IC50 of 0.1 nM for APP23 and APP51/16 primary neurons.

  Catalog
Abmole Inhibitor Catalog




Keywords: LY3039478, Crenigacestat supplier, Gamma-secretase/Beta-secretase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.